Inhibrx Biosciences (INBX) Proxy filing summary

Executive summary

• The annual meeting is scheduled for May 28, 2025, in a virtual-only format, with stockholders able to vote and submit questions online.

• The record date for voting eligibility is April 1, 2025, with 14,475,904 shares outstanding.

• The agenda includes electing two Class I directors, ratifying the appointment of BDO USA, P.C. as auditor, and other business.

• Proxy materials are distributed primarily online to expedite delivery, reduce costs, and conserve resources.

Voting matters and shareholder proposals

• Stockholders will vote on electing two Class I directors for terms ending in 2028 and ratifying BDO USA, P.C. as auditor for 2025.

• The board recommends voting FOR both director nominees and the auditor ratification.

• Shareholder proposals for the 2026 meeting must be submitted between January 28 and February 27, 2026.

Board of directors and corporate governance

• The board consists of five members divided into three classes, with annual elections for expiring terms.

• All directors except the CEO are independent under Nasdaq rules.

• Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all with independent members.

• The company has adopted a Corporate Code of Conduct, Whistleblower Policy, Insider Trading Policy, and Clawback Policy.

• Board meetings and committee attendance met required thresholds, and all directors attended the 2024 annual meeting.